DrugsControl Media Services
DrugsControl.org

News Detail

Zydus Lifesciences gets WHO nod for API used in kala-azar treatment (26-02-2024)

Mumbai, 26 Feb 2024: Ahmedabad-headquartered Zydus Lifesciences has received the World Health Organisation’s (WHO’s) prequalification approval for the active pharmaceutical ingredient (API) called Miltefosine, to treat Leishmaniasis or Kala Azar, the company said.
View Details

Source : Business Standard
Zydus Lifesciences WHO World Health Organization healthcare sector

Related News